Overall, these findings indicate a shared EV lipidomic signature in GBA1-PD, predominantly driven by disturbances in neutral lipids and sphingolipids, with mutation-specific patterns revealing a broader and more severe lipid remodeling in p.N370S carriers and a more targeted sphingolipid dysregulation in p.L444P carriers. The gene discussed is GBA1; the disease is Parkinson disease.